NASDAQ: ALXO - ALX Oncology Holdings Inc.

Rentabilidade por seis meses: -90.19%
Setor: Healthcare

Cronograma de promoção ALX Oncology Holdings Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

ALX Oncology Holdings Inc., иммуноонкологическая компания на клинической стадии, специализируется на разработке методов лечения пациентов, борющихся с раком. Его ведущим продуктом-кандидатом является ALX148, блокирующий CD47 терапевтический препарат, используемый для лечения миелодиспластических синдромов и острого миелоидного лейкоза, а также ряда показаний к солидным опухолям, включая плоскоклеточную опухоль головы и шеи и человеческий эпидермальный рецептор фактора роста 2, положительный для карциномы желудочно-пищеводного перехода.

Mais detalhes
Компания была основана в 2015 году и базируется в Берлингейме, штат Калифорния.

Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

P/S 2844.74
P/BV 2.47
EV/EBITDA 0.1917
EBITDA -0.0188
Цена ао 1.53
Сайт http://www.alxoncology.com
Число акций ао 0.04299 млрд
Выручка 0.0048
Див.доход ао 0
ISIN US00166B1052
Валюта usd
IPO date 2020-07-17
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Alteração de preço por dia: -7.83% (1.66)
Alteração de preço por semana: -5.56% (1.62)
Alteração de preço por mês: -29.82% (2.18)
Alteração de preço em 3 meses: -76.85% (6.61)
Mudança de preço em seis meses: -90.19% (15.6)
Mudança de preço por ano: -80.13% (7.7)
Mudança de preço em 3 anos: -95.72% (35.78)
Mudança de preço desde o início do ano: -80.13% (7.7)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 4.4 4
P/BV 3.42 5
P/E 0 0
EV/EBITDA -3.8 0
Total: 3.75

Eficiência

Nome Significado Nota
ROA, % -66.3 0
ROE, % -84.76 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0662 10
Total: 9

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -42.86 0
Rentabilidade Ebitda, % 801.29 10
Rentabilidade EPS, % 326.73 10
Total: 8
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
11.07.2024 15.07.2024 Pons Jaume
PRESIDENT & CSO		 Oferta 7.9 158 000 20000 0 -0.05 link
11.07.2024 15.07.2024 Pons Jaume
PRESIDENT & CSO		 Comprar 0.99 19 800 20000 0 0.05 link
05.07.2024 09.07.2024 Pinto Shelly
SVP, FINANCE AND CAO		 Oferta 5.5 10 027 1823 0 0 link
04.06.2024 06.06.2024 Pons Jaume
PRESIDENT & CSO		 Oferta 8.43 168 600 20000 0 -0.05 link
04.06.2024 06.06.2024 Pons Jaume
PRESIDENT & CSO		 Comprar 0.99 19 800 20000 0 0.05 link
14.03.2024 18.03.2024 Lettmann Jason
CHIEF EXECUTIVE OFFICER		 Comprar 11.31 49 764 4400 0 0.01 link

Instituições Volume Compartilhar, %
venBio Partners LLC 9699925 19.34
FMR, LLC 7472821 14.9
Vivo Capital, LLC 4220048 8.41
Redmile Group, LLC 3659264 7.3
Cormorant Asset Management, LP 3142079 6.27
Orbimed Advisors LLC. 3095000 6.17
Blackrock Inc. 2235093 4.46
Vestal Point Capital, LP 1655000 3.3
Vanguard Group Inc 1502409 3
MPM BioImpact Capital LLC 1264759 2.52

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Avantis U.S. Equity ETF 0.00004 30.365392144069 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.19423 63.040315712071 0.33
ProShares Ultra Nasdaq Biotechnology 0.00742 51.697637072723 0.85651
Dimensional US Core Equity Market ETF 0.00002 30.983243755928 1.40618
ProShares Hedge Replication ETF 0.00043 5.9237999659878 1.47892
Invesco Nasdaq Biotechnology ETF 0.01087 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.00097 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00082 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.00129 26.701717953559 2.50476
Inspire Small/Mid Cap ETF 0.06571 28.6475145255 1.92038
iShares Micro-Cap ETF 0.01828 34.327031588619 1.54048
iShares Russell 2000 Growth ETF 0.00513 38.042556988 0.6026
iShares Russell 3000 ETF 0.00013 31.230028873917 1.43482
iShares Morningstar Small-Cap ETF 0.00097 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00082 682.83677107207 0.72598
iShares Morningstar Small-Cap Value ETF 0.00129 226.82308420057 2.50476
Schwab U.S. Small-Cap ETF 0.00159 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.00014 -56.193181818182 1.43354
ProShares UltraPro Russell2000 0.00148 89.821266282945 1.47873
Vanguard U.S. Momentum Factor ETF 0.07 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0 32.773459189339 1.48801
Principal Healthcare Innovators ETF 0.01087 618.4964157054 0.8416
Future Tech ETF 0.01087 426.33969118983 0.8416



Supervisor Cargo Pagamento Ano de nascimento
Dr. Jaume Pons Ph.D. Founder, President, Chief Scientific Officer & Director 856.29k 1966 (58 anos)
Dr. Sophia Randolph M.D., Ph.D. Chief Medical Officer & Director 637.24k 1968 (56 anos)
Dr. Michael Chang Ph.D. Vice President of Operations N/A
Ms. Shelly Pinto Senior VP of Finance & Chief Accounting Officer 508.26k 1977 (47 anos)
Mr. Peter S. Garcia M.B.A. Chief Financial Officer 631.11k 1962 (62 ano)
Dr. Athanasios Tsiatis M.D. Senior Vice President of Clinical Development N/A
Dr. Christopher Byrd J.D., Ph.D. General Counsel N/A
Mr. Jason W. Lettmann CEO & Director 60.5k 1977 (47 anos)
Dr. Lin Yeong-Liang M.D., M.S. Senior Vice President of Drug Safety & Pharmacovigilance N/A
Caitlyn Doherty Manager of Investor Relations & Corporate Communications

Endereço: United States, Burlingame, CA , 866 Malcolm Road - abrir no Google Maps, abrir mapas Yandex
Site: http://www.alxoncology.com